Showing 1 - 7 results of 7 for search 'Marina Otten', query time: 0.03s Refine Results
  1. 1
    Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study

    Development, Feasibility, and Acceptability of the Electronic Patient Benefit Index for Psoriasis in Clinical Practice: Mixed Methods Study by Marina Otten, Vahid Djamei, Matthias Augustin

    Published 2024-08-01
    Get full text
    Article
  2. 2
    Exploring Acceptability, Barriers, and Facilitators for Digital Health in Dermatology: Qualitative Focus Groups With Dermatologists, Nurses, and Patients

    Exploring Acceptability, Barriers, and Facilitators for Digital Health in Dermatology: Qualitative Focus Groups With Dermatologists, Nurses, and Patients by Patrick Reinders, Matthias Augustin, Anastasia Fleyder, Marina Otten

    Published 2024-09-01
    Get full text
    Article
  3. 3
    New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects in Germany

    New method of measuring subjective well-being: prospective validation study of the ‘Daily Experience Sampling Questionnaire’ (DESQ) in patients with psoriasis and healthy subjects... by Matthias Augustin, Natalia Kirsten, Ibrahim Nergiz, Ulrich Schiffner, Marina Otten

    Published 2020-12-01
    Get full text
    Article
  4. 4
    Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021

    Attitudes Toward and Use of eHealth Technologies Among German Dermatologists: Repeated Cross-Sectional Survey in 2019 and 2021 by Matthias Augustin, Patrick Reinders, Toni Maria Janke, Klaus Strömer, Ralph von Kiedrowski, Natalia Kirsten, Alexander Zink, Marina Otten

    Published 2024-02-01
    Get full text
    Article
  5. 5
    The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany

    The IMPACT of the COVID-19 Pandemic on Prescription Drug Use in Patients with Psoriasis Vulgaris in Germany by Maria Kahn, Steffeni Papukchieva, Elizabeth Jacyshyn-Owen, Stefan Grimm, Markus Eberl, Sebastian Schneeweiss, Marina Otten, Matthias Augustin, Benjamin Friedrich

    Published 2023-09-01
    Get full text
    Article
  6. 6
    Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research

    Measuring Quality of Life in Hidradenitis Suppurativa: Development and Validation of a Disease-specific Patient-reported Outcome Measure for Practice and Research by Marina Otten, Matthias Augustin, Christine Blome, Janine Topp, Marina Niklaus, Caroline Hilbring, Falk G. Bechara, Andreas Pinter, Christos C. Zouboulis, Florian Anzengruber, Natalia Kirsten

    Published 2023-01-01
    Get full text
    Article
  7. 7
    Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS

    Development and Validation of a Disease-specific Outcomes Tool for the Assessment of Patient Benefits of Treatment for Hidradenitis Suppurativa: the PBI-HS by Natalia Kirsten, Matthias Augustin, Christine Blome, Janine Topp, Richard Schwager, Falk G. Bechara, Gefion Girbig, Andreas Pinter, Florian Anzengruber, Mareen Lindegaard, Christos C. Zouboulis, Marina Otten

    Published 2025-03-01
    Get full text
    Article

Search Tools: